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1. Introduction
  N-substituted imidazoles represents a class of heterocyclic 
analogues having valuable pharma-cological properties 
such as antiparasitic[1], antifungal[2], antimicrobial[3-7], 
and antidepressant[8] activity. It has been reported that 
N-alkylimidazoles with the most simple structure posses 
inhibitory effects on microsomal oxidation[9] cytotoxic[10] 
and antifungal[3] activity. Some imidazole drugs have 
surface activity and are able to damage membranes directly 
when used at a high concentration for a very short time, 
independently of the culture medium and growth rate. 
When in direct contact[11,12] imidazoles interact directly 
with the double lipid layer[13] of the membrane structure, 
probably by binding to the unsaturated fatty acid part of 
the phospholipids components of the membrane. Some 
microorganisms show resistance to imidazole action due to 
outer membrane modifications[14-16].
  The development of new and different antimicrobial 
agents has been a very important step. The resistance of 
common pathogens to standard antibiotic therapy is rapidly 
becoming a major health problem throughout the world. 
There is continuously increased incidence of multidrug-
resistant gram-positive bacteria and infections caused by 
staphylococcus aureus (S. aureus) (multidrug-resistant S. 
aureus and coagulase negative staphylococcus), enterococci, 
and pneumococci are particularly problematic[14]. Much of 
the research programmer efforts are oriented toward the 
design of new and available antimicrobial drugs, but due 
to unsatisfactory status of present drugs’ side effects, and 
the acquisition of resistance by the infecting organisms to 
the present drugs[9]. There is a real perceived need for the 
discovery of new compounds endowed with antibacterial 
property, possibly acting through mechanisms of action 
that are distinct from those of the well-known classes of 
antibacterial agents to which many clinically relevant 
pathogens are now resistant[10]. 
  Khabnadideh et al reported synthesis of N- alkylated 
derivatives of imidazole as antibacterial agents, 
antibacterial effects of these compounds were investigated 
to achieve the relationship between the length of the 
alkyl chain and antibacterial activity[17]. 2-substituted-
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4,5-diphenyl-N-alkyl imidazole derivatives showed 
antinociceptive and antiinflammatory activities. In this 
study, antibacterial effects of synthesized compounds were 
investigated to achieve the effect of the phenyl group and 
length of the alkyl chain on antibacterial activity. We have 
now synthesized some new 4,5- disubstituted-N- alkyl 
imidazole derivatives (2a-2e) incorporating substituted 
phenyl moiety at position 2nd. These compounds were 
characterized by their elemental and spectral analyses (IR, 
1HNMR, 13CNMRand mass spectra).
2. Material and methods
  All chemicals were of analytical grade and were used 
directly. All melting points were determined in PMP-DM 
scientific melting point apparatus and were uncorrected. 
Infrared spectra were recorded on a Perkin Elmer RX-1 
model spectrophotometer using KBr pellets. 1HNMR 
spectra were acquired on a Bruker Avance-2 model 
spectrophotometer using DMSO as a solvent and TMS as 
internal reference (chemical shifts in δ, ppm). Mass spectra 
(MS) were recorded on Schimadzu GC-MS. All products were 
purified by recrystallisation. The reactions were followed 
up and the purity of products was carried out on pre-coated 
TLC plates (Silica gel 60, Merck), visualizing the spots under 
ultraviolet light. Column chromatography was performed on 
Merck silicagel (60-120 mesh).
2.1. General procedure for the synthesis of 2(4-substituted-
phenyl)-4,5-diphenyl-1H-imidazoles (1a-1e)
  A mixture of benzil (10 mmol) and ammonium acetate 
(0.1 mol) (immediately fused) in glacial acetic acid (25 mL) 
was stirred at 80- 100 曟 for 1 h under nitrogen atmosphere 
( To prevent incorporation of any atmospheric impurities 
and moisture) . Substituted aldehydes (10 mmol) in glacial 
acetic acid (5 mL) was added drop-wise over a period of 
15-20 min at the same temperature and stirred for another 
4 h, the progress of the reaction was monitored by TLC test 
using ethyl acetate as eluent. After completion of reaction, 
mixture was allowed to stand at room temperature. The 
resulting homogenous solution was poured over crushed ice 
(200 g), The yellow precipitate was collected by filtration and 
washed with cold water and dried under vacuum.Product 
was recrystallized from ethyl acetate thrice to afford the pure 
compound .
 
    
R1 = 2a = p- NO2, 2b = m- NO2, 2c = p- Cl, 2d = o- Cl, 2e = m- Br, 
R2 = Butyl
Figure 1. Various steps involved in synthesis of 2-substituted-4,5-
diphenyl-N-alkyl imidazole derivatives.
 
Compound (1a): m.p. 144-148 曟 yield 70% 
1H NMR DMSO: 7.22-7.74 
(m, 12H, Ar-H), 8.12 (d, 2H, Ar-H), 12.9 (s, 1H, N-H), IR (cm-1) 3068.0, 
3014.8, 1674, 1348, 758. Compound (1b): m.p. 135-140 曟 yield 62% 
1H NMR DMSO: 7.22-7.58 (m, 11H, Ar-H), 8.11 (d, 1H, Ar-H), 8.55 (s, 
1H, Ar-H), 13.1 (s, 1H, N-H), IR (cm-1 ) 3066.0, 3018, 1680, 1337, 750. 
Compound (1c): m.p. 118-122 曟 yield 55% 
1H NMR DMSO: 7.3-7.41 
(m, 12H, Ar-H), 7.51-7.59 (m, 2H, Ar-H), 13.1 (s, 1H, N-H), IR (cm-1) 
3054.8, 1594.6, 1092.9, 771.9. Compound (1d): m.p. 124-129 曟yield 
53% 1H NMR DMSO: 7.20-7.52 (m, 14H, Ar-H), 12.9 (s, 1H, N-H), 
IR (cm-1 ) 3045.1, 1590.2, 1090.2, 768.7. Compound (1e): m.p. 108-
112 曟 yield 53%
1H NMR DMSO: 7.22-7.34 (m, 13H, Ar-H), 7.67 (s, 
1H, Ar-H), 13.1 (s, 1H, N-H), IR (cm-1 ) 3051.0, 1595.2, 1071.5, 892.0, 
822.9, 747.1.
2.2. General procedure for the synthesis of 1-butyl- 2 
(4-substituted phenyl) -4,5-diphenyl -1H-imidazoles (2a-
2e)
  Compounds 2a-2e are synthesized from 1a-1e, K2CO3 
(7 mmol) was added to intermediates (1a-1e) (5.8 mmol), 
in DMF (25 mL) at 0 曟 under nitrogen. After 15 min, 
butyl iodide (6 mmol) was added in drop wise at 0 曟 and 
continued stirring for 2 h, and then the mixture was stirred 
overnight at room temperature and poured over crushed ice 
(150 g). Reaction mixture was filtered and washed with ice 
cold water several times to remove DMF and dried in an 
oven. Product was recrystallized from ethyl acetate thrice to 
afford the pure compound. Product was purified by column 
chromatography using ethyl acetate/n-hexane as eluent.
  Compound (2a). 1H NMR DMSO: 0.64 (t, 3H, -CH3), 0.86-0.94 
(m, 2H, -CH2), 1-1.3 (m, 2H, -CH2), 3.72-3.84 (t, 2H, -CH2), 7.18-
7.41 (m, 10H, Ar-H), 7.61 (d, 2H, Ar-H), 8.1 (d, 2H, Ar-H); IR (cm-1) 
3068.0, 2995.0, 2970.0, 1674, 1348.29, 758.05; 13C NMR (50 MHz, 
CDCl3) 11.2 (-CH3), 17.8 (-CH2), 28.1 (-CH2), 34.2 (-CH2), 118.7, 122.2, 
128.2, 128.3, 133.2, 133.4, 142.1, 152.3 (Aryl-C), 128.2, 130.1, 148.2 
(imidazole-C); MS:  (M+, 100) 396; Anal. Calcd. for  C25H23N3O2 : C 
75.55, H 5.83, N 10.57 Found: C 75.48, H 5.75, N 10.51.
  Compound (2b). 1H NMR DMSO: 0.77 (t, 3H, -CH3), 1.12 (m, 2H, 
-CH2), 1.44 ( m, 2H, -CH2), 2.99 (t, 2H, -CH2),7.32-7.67 (m, 11H, 
Ar-H), 8.33 (d, 1H, Ar-H), 8.50 (s, 1H, Ar-H); IR (cm-1) 3057.0, 2965.3, 
1680, 1522.2, 1347.8, 970.5, 805.5, 766.1; 13C NMR (50 MHz, CDCl3) 
11.8 (-CH3), 16.8 (-CH2), 30.1 (-CH2), 31.2 (-CH2), 119.2, 119.9, 
126.2, 129.2, 133.1, 133.3, 145.3, 155.3 (Aryl -C), 126.2, 133.1, 153.2 
(imidazole-C), MS:  (M+, 100) 396; Anal. Calcd. for  C25H23N3O2 : C 
75.55, H 5.83, N 10.57 Found C 75.42, H 5.79, N 10.53.
Compound (2c). 1H NMR DMSO: 0.63 (t, -CH3), 1.12 (m, 2H, -CH2), 1.32 
(m, 2H, -CH2), 3.82 (t, 2H, -CH2), 7.33-7.48 (m, 12H, Ar-H), 7.64-
7.74 (m, 2H, Ar-H); IR (cm-1) 3058.8, 2955.8, 1590.8, 1089.9, 768.1; 
13C NMR (50 MHz, CDCl3) 11.2 (-CH3), 15.8 (-CH2), 30.3 (-CH2), 34.2 
(-CH2), 117.1, 118.9, 128.3, 128.7, 132.6, 132.3, 133.3, 135.3 (Aryl-C), 
125.3, 132.8, 150.1 (imidazole-C), MS:  (M+, 100) 386; Anal. Calcd. for 
C25H23N2Cl : C 77.61, H 5.99, N 7.24 Found: C 77.57, H 5.84, N 7.19.
  Compound (2d). 1H NMR DMSO: 0.68 (t, -CH3), 1.02 (m, 2H, -CH2), 
1.28 (m, 2H, -CH2), 3.19 (t, 2H, -CH2),7.20-7.52 (m, 14H, Ar-H), 
3045.1, 1590.2, 1090.2, 768.7; 13C NMR (50 MHz, CDCl3) 10.8 (-CH3), 
13.3 (-CH2), 28.2 (-CH2), 32.4 (-CH2), 118.2, 119.8, 119.3, 125.2, 130.2, 
131.1, 137.7, 139.3 (Aryl-C), 122.2, 134.2, 154.8 ( imidazole-C), MS: 
(M+, 100) 386; Anal. Calcd. for  C25H23N2Cl : C 77.61, H 5.99, N 7.24 
Found: C 77.58, H 5.87, N 7.16.
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  Compound (2e). 1H NMR DMSO: 7.18-7.26 (m, 4, Ar-H), 7.34-
7.42 (m, 10H, Ar-H), 7.71 (s, 1H, Ar-H); IR (cm-1) 3053.2, 2953.8, 
1615.2, 1071.8, 890.0, 742.2; 13C NMR (50 MHz, CDCl3) 10.2 (-CH3), 
12.9 (-CH2), 22.4 (-CH2), 29.4 (-CH2), 118.2, 120.8, 124.3, 124.2, 
131.2, 131.1,132.3,132.8, 135.7, 138.3, (Aryl-C), 126.2, 133.2, 152.9 
(imidazole-C), MS:  (M+, 100) 430; Anal. Calcd. for C25H23N2Br : C 69.61, 
H 5.37, N 6.49 Found: C 69.56, H 5.32, N 6.38.
2.3. Antibacterial assays 
  The in vitro antibacterial activity[18]  of synthesized 
compounds 4a-4e was carried out for 24 h culture of 
five selected bacteria. The bacteria organisms used were 
Escheria coli (E. coli) , S. aureus, Bacilus subtilus (B. 
subtilus). All the test organisms are clinical isolates of 
human pathogens obtained from the IMTECH Chandigarh, 
India. Cultures were brought to laboratory conditions by 
resuscitating the organism in buffered peptone broth and 
thereafter agar medium and incubated at 37 曟 for 24 h. 
The antibacterial activity was performed by cylinder wells 
diffusion technique. The medium (7 g nutrient agar in 250 mL 
distilled water, auto claved at 115 曟 for 15 min) was cooled 
to 50 曟. 20 mL of the medium was poured into a sterile Petri 
dish and allowed to solidify. It was allowed to stay for 8 h 
and observed for contamination. 
  The sterility of the medium was tested after sterilization 
10 mg of synthesized compounds was dissolved in 10 mL of 
DMF and made and further diluted to give a concentration 
of 50-150 毺g/mL, a colony of each test organism was subcultured 
on nutrient broth and incubated at 37 曟 for 8 h. This was 
then used to flood the agar plates. After setup the culture 
media, a sterilized glass tubes (5 mm diameter) was used 
aseptically to scoop out the media to make wells, two drops 
(0.1 mL) of the sample solution were filled into these wells 
aseptically. The plates were incubated at 37 曟 for 24 h. 
After incubation, the Zone of inhibition was then measured 
and compared with that of the standard (norfloxacin).
3. Results
  All the synthesized compounds were confirmed by 
spectroscopical techniques and evaluated for antimicrobial 
activity against S. aurius, B. subtilus and E. coli. The 
substituents of the compounds with physicochemical 
properties are given in Table 1. These compounds showed 
antibacterial activity (zone of inhibition) against S. aurius 
ranged from 3-9 mm in diameter, B. subtilus, 4 -8 mm, and 
E. coli 5 -12. Out of 2a-2e, only 2a and 2b showed some sort 
of activity but none of them had considerable activity than 
the standard (Table 2).
Table 1
Physicochemical properties of compounds 2a-2e. 
Compounds R1 R2 Molecular formula Melting point (曟) Color
2a      p- NO2 -CH2-CH2-CH2-CH3 C25H23N3O2 168-174 Dark yellow
2b      m- NO2 -CH2-CH2-CH2-CH3 C25H23N3O2 166-174 Light yellow
2c      p- Cl -CH2-CH2-CH2-CH3 C25H23N2Cl 145-148 Off white colour
2d      o- Cl -CH2-CH2-CH2-CH3 C25H23N2Cl 167-170 White
2e      m- Br -CH2-CH2-CH2-CH3 C25H23N2Br 119-125 Yellowish white
Table 2
Antibacterial activity of 1-butyl- 2 (4-substituted phenyl) -4,5-diphenyl -1H-imidazoles  derivatives-zone of inhibition (mm, %).
     
 Compounds
Zone of inhibition
S. aurius B. subtilis E. coli
50 (毺g/mL) 150 (毺g/mL) 50 (毺g/mL) 150 (毺g/mL) 50 (毺g/mL) 150 (毺g/mL)
2a 5 (23.09) 9 (42.85) 4 (19.04) 8 (38.09) 7 (33.33) 9 (42.85)
2b 3 (14.28) 7 (33.33) 4 (19.04) 7 (33.33) 6 (28.57) 9 (42.85)
2c 5 (23.09) 6 (28.57) 6 (28.57) 7 (33.33) 5 (23.09) 8 (38.09)
2d 5 (23.09) 6 (28.57) 6 (28.57) 6 (28.57) 5 (23.09) 8 (38.09)
2e 4 (19.04) 7 (33.33) 4 (19.04) 7 (33.33) 5 (23.09) 8 (38.09)
A* 21 - 21 - 21 -
  A* = Norfloxacin at concentration 50 毺g/mL.
4. Discussion
  In this work, the intermediate 2 (4-substituted-phenyl)-
4,5-diphenyl- 1H-imidazoles (1a-1e) was synthesized 
using the reported procedure[19]. Wen-Long Pan reaction 
was carried out by reacting benzil and ammonium acetate 
with substituted aldehydes in glacial acetic acid (1a-
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1e). These 2(4-substituted-phenyl)-4,5-diphenyl-1H 
imidazoles derivatives react with butyl iodide give the 
corresponding 1-butyl- 2 (4-substituted phenyl) -4,5-
diphenyl -1H-imidazoles derivatives (2a-2e). The best 
yield of the compounds is achieved when the reaction is carried 
out at 0 曟 in presence of DMF. These reactions are summarized in 
Figure 1. Yields were moderate to fair (50-77%). The purity of 
the compounds was monitored by TLC and the synthesized 
compounds were recrystallized by appropriate solvents 
(Ethyl acetate). All final substituted imidazole analogues 
are analyzed by different spectroscopic technique such as 
IR, NMR, mass spectroscopy and by elemental analysis. 
These derivatives were further evaluated for antibacterial 
activity. Literature survey revealed that 4,5 disubstituted 
N- alkylated imidazole ring has anti-inflammatory and 
analgesic activities.  Antibacterial activity of synthesized 
compounds was much inferior compare to standard drug 
norfolxacin.
  Most of the newly synthesized compounds were tested 
for their antibacterial activity in vitro against bacterial 
strains such as E. coli, B. subtillis and S. aurius, employing the 
nutrient agar disc diffusion method 14 at 50 and 150 毺g/mL 
concentrations. Norfloxacin shows inhibition zone of 21 mm 
but only 2a had maximum 12 mm zone of inhibition against 
E. coli the activity of 2a and 2b is due to presence of chain 
length of 4 C atom and NO2 group at phenyl ring. The rest of 
the compounds were found to be moderately active, slightly 
active or inactive against the tested microorganisms. The 
results of antimicrobial testing are compared with those 
of standards norfloxacin as antibacterial agents. For each 
biological activity test, three to four experiments were 
performed and the average zone of inhibition is reported in 
this work.
  All the synthesized compounds are shown moderate 
activity against the tested bacteria S. aurius, B. subtilus, 
and E. coli. So, further structural modification is necessary 
to improve the antibacterial action of 2-substituted-4,5-
diphenyl-N-alkyl imidazole derivatives
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